aa melanotic Congenital melanocytic neoplasms: clinical, histopathological and recent molecular developments | Virchows Archiv Aberrant intermediate filament and synaptophysin

30 GrotenK.VanackerH.DutilleulC.BastianF.BernardS.CarzanigaR.et al (2005)

Yan et al (Yan et al., 2020)

the compositions comprise a cannabinoid (e.g., CBD) and a cofactor or precursor thereof (e.g., niacinamide) at a molar ratio of about 50 : 1, about 49 : 1, about 48 : 1, about 47 : 1, about 46 : 1, about 45 : 1, about 44 : 1, about 43 : 1, about 42 : 1, about 41 : 1, about 40 : 1, about 39 : 1, about 38 : 1, about 37 : 1, about 36 : 1, about 35 : 1, about 34 : 1, about 33 : 1, about 32 : 1, about 31 : 1, about 30 : 1 , about 29 : 1 , about 28 : 1 , about 27 : 1 , about 26 : 1 , about 25 : 1 the compositions comprise a cannabinoid (e.g., CBD) and a mitophagy stimulant (e.g., urolithin A) at a molar ratio of between about 50:1 and about 1:80

Nutrients 10 , 1267 (2018)

Tool: Tracking Diet 01:19:50 The Norton Method